Kunming Biomed International (KBI) is a leading Contract Research Organization (CRO) providing high-quality services for new drug discovery and development with nonhuman primate (NHP) animal models. We are dedicated to improving the healthcare by translating innovative therapeutics to clinical applications through our evaluation in NHP disease models. KBI has AAALAC accredited vivarium, state-of-the-art research facilities, extensive colonies of SPF and purpose-bred NHPs. We conduct adjacent studies including PK/PD, pathology and exploratory toxicology in industry- compliant high quality and uphold the highest ethical standards for animal care and welfare.